skip to main content

FLOT4 Gastric — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

ModerateGI CancersFLOT4 GastricSCE Medical Oncology

A 65-year-old man with gastric cancer is being considered for perioperative FLOT chemotherapy (FLOT4 trial). What does FLOT4 show?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CPerioperative FLOT (fluorouracil/leucovorin/oxaliplatin/docetaxel: 4 cycles pre + 4 cycles post-surgery) significantly improved OS compared with ECF/ECX (median OS 50 vs 35 months) — FLOT is now the standard perioperative regimen for resectable gastric cancer

FLOT4 (Al-Batran et al Lancet 2019): perioperative FLOT vs ECF/ECX for resectable gastric/GOJ adenocarcinoma. OS: 50 vs 35 months. pCR rate: 16% vs 6%. FLOT replaced ECF/ECX as the global standard. NICE recommends FLOT-based perioperative chemotherapy.

Reference: FLOT4 Al-Batran et al Lancet 2019; NICE NG83; ESMO 2024 Gastric